CRBN and Miyoshi myopathy: More recently, it has been shown that IMiDs can enhance NK and T cell cytotoxicity by triggering granzyme-B via either CRBN or ZAP-70 dependent mechanisms, thus providing the rationale for novel therapeutics to activate ZAP-70 in MM (130).